Genelux Stock (NASDAQ: GNLX) stock price, news, charts, stock research, profile.
You can purchase shares of Genelux (NASDAQ:GNLX) through any online brokerage.
Other companies in Genelux’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR), Inovio Pharmaceuticals (NASDAQ:INO) and OS Therapies (AMEX:OSTX).
Genelux has a consensus price target of $23.00.
The stock price for Genelux (NASDAQ: GNLX) is $2.27 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Genelux.
Genelux’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Genelux.
Genelux is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.